Essential Workforce Protection

Protect essential workers who maintain food, water, power, healthcare, and public order from any respiratory pandemic.

Last updated: May 11, 2026 · Public updates are batched quarterly, with urgent corrections as needed.

5-year budget target

$1000M

Pillar

Defend

Current Status of the Field

Technology

Reusable elastomeric respirators, fit-testing systems, and improved respiratory protection products exist, but comfort, fit, maintenance, and high-volume logistics still need work.

Policy

Pandemic PPE plans remain nationally fragmented; U.S. launch milestones can test the model, but the strategic requirement is global essential-workforce protection.

Bottleneck

The bottleneck is public-interest stockpile governance and distribution: who counts as essential, where PPE is held, and how it reaches workers within 24 hours without appearing like private hoarding.

The Problem

If a highly transmissible respiratory pathogen with greater lethality than COVID-19 emerged tomorrow, we could not adequately protect the people who keep society running. Global stockpiles of high-quality respiratory protection are far too small to cover the essential workforce, distribution systems have not been tested at the required speed and scale, critical-infrastructure workforce maps are incomplete, and next-generation respirators suitable for extended daily use are not yet widely available.

The Solution

Existing technologies — especially reusable elastomeric respirators — can provide robust protection at relatively low cost. The primary bottleneck is not invention but stockpiling, procurement, distribution planning, workforce mapping, and surge capacity. Philanthropic purchases should be held in trust for public distribution under predefined rules, not treated as private reserves. The urgent priority is to begin protecting the essential workforce with U.S. launch milestones that can become a global model and scale fast in a crisis.

Objectives

  • Global stockpiles provide 90+ days of high-quality respiratory protection (especially reusable elastomeric respirators) for all essential workers at the onset of any respiratory pandemic, with initial U.S. milestones used as a launch point rather than the ceiling of ambition
  • Stockpiled respiratory PPE achieves easy fit, protects against maximally transmissible and virulent respiratory pathogens, and is comfortable enough for extended daily use
  • Global PPE stockpiles plus surge manufacturing capacity are adequate to keep the essential workforce protected throughout any respiratory pandemic
  • Distribution systems are tested and ready to deliver PPE to essential workers within 24 hours of threat identification
  • Critical infrastructure and essential-workforce categories are mapped by jurisdiction so stockpiles and distribution plans cover the workers needed to maintain food, water, power, healthcare, public order, and other core services

Urgent 2026 Milestone

Launch a U.S. essential-workforce PPE initiative capable of beginning stockpile buildout, critical-infrastructure workforce mapping, and rapid-distribution planning, with stockpiles held in trust for public distribution.

Long-term Targets

Respirator readiness

90+ days of supply by 2029

Essential-worker coverage within 24 hours

50% by 2029 (to be revisited)

Year-by-Year

Philanthropy

  • Fund initial purchases to begin building respiratory PPE stockpiles for the essential workforce, held in trust for public distribution under predefined rules
  • Fund critical-infrastructure and essential-workforce mapping for initial jurisdictions
  • Fund development and exercise of distribution plans for rapid PPE delivery
  • Fund R&D on next-generation elastomeric respirators and other respiratory protection measures

Private Sector

  • Supply initial PPE stockpile orders and participate in logistics and distribution exercises
  • Support product development and manufacturing readiness for improved respirators

Government

  • Appropriate funds and establish initial national respiratory PPE stockpiles for essential workers
  • Define essential-workforce categories and public distribution rules for emergency PPE release
  • Clarify and accelerate regulatory pathways for respiratory PPE
  • Develop public-sector distribution plans and exercise them

Philanthropy

  • Continue building PPE stockpiles held in trust for public distribution and fund readiness exercises for 24-hour delivery
  • Continue far-UVC and other biohardening pilots while strengthening the evidence base and playbooks
  • Continue catalyzing government-led MCM platform work, distributed manufacturing, market incentives, and clinical trial preparedness
  • Fund concrete operational response exercises and communication-playbook development

Private Sector

  • Expand PPE manufacturing and stockpile support
  • Continue deployment support for germicidal-lighting, filtration, decontamination, and air-quality pilots
  • Advance candidate MCMs through development milestones and maintain rapid trial and manufacturing readiness
  • Participate in concrete public-private response exercises tied to named playbooks

Government

  • Expand respiratory PPE stockpiles and exercise rapid-delivery systems
  • Continue regulatory and policy support for biohardening pilots, public-building standards, and emergency adaptation protocols
  • Lead development of vaccine, diagnostic, and therapeutic platforms, distributed manufacturing agreements, and emergency pathways
  • Lead government participation in exercises for specific coordination products and playbooks
2028 — Scale and enforceDefend-level actions

Philanthropy

  • Continue funding stockpile expansion toward broad essential-workforce coverage and support surge-capacity agreements
  • Fund wider deployment of biohardening technologies, especially in underserved areas, public buildings, and critical settings
  • Support late-stage development of priority MCM platforms, distributed manufacturing, market incentives, and end-to-end exercises validating progress toward 100-day capability
  • Fund international response exercises testing specific activation, procurement, communication, and playbook workflows

Private Sector

  • Maintain or expand surge capacity for PPE and support broader logistics readiness
  • Manufacture and install air-decontamination and biohardening technologies at larger scale
  • Maintain geographically distributed manufacturing readiness for platform vaccine surge production and support scale-up of diagnostics and therapeutics
  • Support cross-border coordination mechanisms for specific products and services

Government

  • Expand national stockpiles and secure surge manufacturing agreements for PPE
  • Adopt or prepare pathogen-resistant building-code reforms, public-building requirements, and government-building retrofits
  • Fund and exercise end-to-end 100-day response capability, distributed manufacturing agreements, and demand guarantees for MCMs
  • Negotiate and test targeted multinational coordination protocols without depending on a new permanent command body

Philanthropy

  • Continue targeted support for final stockpile expansion, public distribution readiness, MCM validation, and communication readiness
  • Support harder-to-fund coordination, playbook testing, and stress-testing work that improves real-world performance

Private Sector

  • Maintain surge capacity and operational readiness for PPE, diagnostics, therapeutics, and vaccines
  • Continue deployment of pathogen-resistant technologies, distributed manufacturing readiness, and annual readiness exercises

Government

  • Maintain stockpiles sufficient for 90+ days of essential-workforce protection at pandemic onset in priority jurisdictions
  • Maintain tested 24-hour PPE distribution systems
  • Exercise full 100-day MCM response capability and specific multinational coordination workflows capable of activation within hours

Philanthropy

  • Support hard-to-fund maintenance, exercises, and improvement work across PPE, built environment, MCM readiness, market incentives, and coordination playbooks

Private Sector

  • Maintain surge manufacturing, resilient supply chains, and operational readiness across PPE and MCMs

Government

  • Maintain stockpiles, manufacturing agreements, demand guarantees, building adaptation, and exercised response workflows as part of permanent national and international readiness architecture